Ototoxic drugs: a review of clinical aspects, histopathologic changes and mechanisms of action.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000962:Antimalarials / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects; D003051:Cochlea / Q000187:drug effects*; D004096:Dihydrostreptomycin Sulfate / Q000009:adverse effects; D007758:Ear, Inner / Q000187:drug effects*; D004976:Ethacrynic Acid / Q000009:adverse effects*; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects; D009355:Neomycin / Q000009:adverse effects; D011042:Poisons; D011247:Pregnancy; D011803:Quinine / Q000009:adverse effects; D013307:Streptomycin / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D011042:Poisons; D007612:Kanamycin; D002738:Chloroquine; D011803:Quinine; D009355:Neomycin; D004976:Ethacrynic Acid; D001241:Aspirin; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin